您当前所在的位置:首页 > 产品中心 > 产品信息
Tetrandrine(Fanchinine)_分子结构_CAS_518-34-3)
点击图片或这里关闭

Tetrandrine(Fanchinine)

产品号 S2403 公司名称 Selleck Chemicals
CAS号 518-34-3 公司网站 http://www.selleckchem.com
分子式 C38H42N2O6 电 话 (877) 796-6397
分子量 622.74988 传 真 (832) 582-8590
纯 度 电子邮件 sales@selleckchem.com
保 存 -20°C Chembase数据库ID: 73023

产品价格信息

请登录

产品别名

标题
Tetrandrine(Fanchinine)
IUPAC标准名
(1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2^{3,6}.1^{8,12}.1^{14,18}.0^{27,31}.0^{22,33}]hexatriaconta-3,5,8(34),9,11,18,20,22(33),24,26,31,35-dodecaene
IUPAC传统名
(1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2^{3,6}.1^{8,12}.1^{14,18}.0^{27,31}.0^{22,33}]hexatriaconta-3,5,8(34),9,11,18,20,22(33),24,26,31,35-dodecaene
别名
S-(+)-Tetrandrine
S
NSC 77037
Hanfangchin A
Fanchinine

产品登记号

CAS号 518-34-3

产品性质

作用靶点 calcium channel
成盐信息 Free Base
保存条件 -20°C

产品详细信息

详细说明 (English)
Research Area: Cancer
Biological Activity:
Tetrandrine (Fanchinine; Hanfangchin A) is a calcium channel blocker with an IC50 of 38.23± 25.77 μM. Tetrandrine (Fanchinine; Hanfangchin A) has anti-inflammatory, immunologic and antiallergenic effects. Tetrandrine (Fanchinine; Hanfangchin A) inhibits the degranulation of mast cells. Tetrandrinehas a "Quinidine like" anti-arrhythmic effect. Tetrandrine (Fanchinine; Hanfangchin A) has been isolated from Stephania tetandra and other Chinese and Japanese Herbs. Tetrandrine (Fanchinine; Hanfangchin A) increased populations of both apoptotic sub-G1 and G1 phase. Tetrandrine-induced growth inhibition was associated with induction of Cdk inhibitor p21, inhibition of cyclin D1 and activation of caspase-3. Tetrandrine (Fanchinine; Hanfangchin A) also affected the expression patterns of cytoskeletons including distribution of F-actin and expression level of microtubule. [1][2][3]References on Tetrandrine(Fanchinine)[2] Int J Oncol., 2002 Dec, 21(6):1239-44.[3] http://en.wikipedia.org/wiki/Tetrandrine, , [1] Cancer Letters, 2008, 268:166–175

参考文献

  • Lee JH et al. Int J Oncol. 2002 Dec;21(6):1239-44.